Retina-Vitreous
2018 , Vol 27 , Num 1
Efficacy of Intravitreal Aflibercept as a First Line Therapy in Macular Telengiectasia Type 1
Uz. Dr., Samsun Eğitim ve Araştırma Hastanesi, Göz Hastalıkları, Samsun - Türkiye
We present a 66 year old male patient who was admitted to our clinic with blurred vision in the right eye, which commenced 6 months
prior. Ophthalmic examination of the patient revealed type 1 macular telangiectasia (MACTEL). As a fi rst line therapy, two occasions
of intravitreal afl ibercepts were administered a month apart. For the fi rst and second post-treatment examinations, visual acuity was 0.7
and 1.0 while the thickness of the macula was measured at 295 ?m and 254 ?m, respectively. At the 12th month post-treatment, visual
acuity was stabilized and sub-intra retinal fl uid was not detected. This case study suggests that intravitreal afl ibercept injection may be
an effective therapy for the treatment of macular edema due to type 1 MACTEL.
Keywords :
Macular telangiectasia type 1, Aflibercept, Juxtafoveal telengiectasia